Compliance with Oral Anti-Diabetic Treatment in Lome
- 1 Internal Medicine Departement, Université de Kara, Kara, Togo
- 2 Internal Medicine Departement, Université de Kara, Kara, Togo
- 3 Internal Medicine Departement, Université de Lomé, Lomé, Togo
- 4 Internal Medicine Departement, Université de Lomé, Lomé, Togo
- 5 Internal Medicine Departement, Université de Lomé, Lomé, Togo
- 6 Internal Medicine Departement, Université de Lomé, Lomé, Togo
- 7 Internal Medicine Departement, Université de Lomé, Lomé, Togo
- 8 Internal Medicine Departement, Université de Lomé, Lomé, Togo
- 9 Internal Medicine Departement, Université de Lomé, Lomé, Togo
Abstract
Objective: The objective of this study was to assess adherence to antidiabetic therapy in type II diabetic patients and factors associated with Lomé. Method: This was a descriptive observational study conducted among diabetics in diabetes care centers from May 1, 2020 to October 1, 2020, for a period of 6 months. Results: A total of 300 patients were questioned. The mean age was 56.61 years (standard deviation = 11.7). The sex ratio was 0.6. All the patients were on drug treatment, 83.4% of whom were on metformin and 37.5% on Glibenclamide. In 58.3% of the cases, the patients were on dual therapy and 96.2% had an abovenormal glycated hemoglobin value. There was a medication adherence problem with poor adherence in 30.7%. Being aged 50 and over (ORC = 1.78, p = 0.048), playing sports (ORR = 1.87, p = 0.046), have reaching a higher level of education (ORR = 5.78, p = 0.005) significantly increased the chances of patients having a good/minimal problem of adherence. Conclusion: Diabetes affects in Togo, more women than men with a predominance of those aged 50 and over. Adherence to therapy remains a challenge.
- Jaffiol, C. (2011) The Burden of Diabetes in Africa: A Major Public Health Problem. Bulletin de l’Académie Nationale de Médecine, 195, 1239-1253. https://doi.org/10.1016/S0001-4079(19)31983-1
- Gelaw, B., Mohammed, A., Tegegne, G., Defersha, A., Fromsa, M., Tadesse, E., et al. (2014) Nonadherence and Contributing Factors among Ambulatory Patients with Antidiabetic Medications in Adama Referral Hospital. Journal of Diabetes Research, 2014, Article ID: 617041. https://doi.org/10.1155/2014/617041
- Tiéno, H., Bouda, M., Ouédraogo, D.D., Traoré, R., Ouédraogo, C. and Drabo, Y.J. (2010) Observance to Antidiabetic Treatment in a Developing Country: The Case in Burkina Faso (Sub-Saharan Africa). Médecine des maladies Métaboliques, 4, 207-211. https://doi.org/10.1016/S1957-2557(10)70046-8
- Kalyango, J.N., Owino, E. and Nambuya, A.P. (2008) Non-Adherence to Diabetes Treatment at Mulago Hospital in Uganda: Prevalence and Associated Factors. African Health Science, 8, 67-73.
- Sabaté, E. (2003) Adherence to Long-Term Therapies: Evidence for Action. World Health Organization.
- Organisation mondiale de la santé (OMS) (2016) Rapport mondial sur le diabète. OMS, Génève, 88 p.
- Girerd, X., Hanon, O. and Vaïsse, B. (2018) Utilisation de l’échelle d’observance EvalObs® dans une population de sujets traités pour une hypertension, une dyslipidémie ou un diabète: enquête FLAHS observance 2017. Annales de cardiologie et d’angéologie, 67, 186-190.
- Ntyonga-Pono, M.P. (2015) L’observance du traitement antidiabétique chez les patients diabétiques au Gabon: Données préliminaires. Médecine des Maladies Métaboliques, 9, 198-202. https://doi.org/10.1016/S1957-2557(15)30043-2
- Rwegerera, G.M. (2014) Adherence to Anti-Diabetic Drugs among Patients with Type 2 Diabetes Mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania-A Cross-Sectional Study. The Pan African Medical Journal, 17, 12-18. https://doi.org/10.11604/pamj.2014.17.252.2972
- Kalyango, J., Owino, E. and Nambuya, A. (2008) Non-Adherence to Diabetes Treatment at Mulago Hospital in Uganda: Prevalence and Associated Factors. African Health Sciences, 8, 67-73.
- Wanvoegbe, F.A., Agbodande, K.A., Alassani, A., Aviansou, A., Gninkoun, J., Amoussou-Guenou, D., et al. (2018) Evaluation de l’observance thérapeutique chez les diabétiques au Bénin. Médecine d’Afrique Noire, 65, 355-361.
- Achouri, M.Y., Tounsi, F., Messaoud, M., Senoussaoui, A. and Abdelaziz, A.B. (2021) Prévalence de la mauvaise observance thérapeutique chez les diabétiques de type 2 en Afrique du Nord. Revue systématique et méta-analyse. Tunisie médicale, 99, 932-945.